retatrutide clinical trials obesity efficacy (RETA) is one of the most promising investigational peptides in research— When will Retatrutide be available

The rate of metabolic bariatric surgery decreased from 2022 to 2023, whereas the use of GLP-1 receptor agonists as anti-obesity medications grew over twofold, a research letter showed

Description Introducing Retatrutide 5mg from SSP Research, a novel multi-receptor peptide currently under investigation for its potential to influence weight management, glucose regulation, and metabolic resilience

3, 2025, pp

doi:10.1016/j.molmet.2019.09.010 Forst T, De Block C, Del Prato S, et al

If you may benefit from the medication, your provider will help you decide whether injectable or semaglutide sublingual drops may suit your needs better

Affiliate links are included